SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-054396
Filing Date
2023-10-20
Accepted
2023-10-20 16:30:02
Documents
5
Period of Report
2023-10-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A sabs_pre14a_fy23_spec_me.htm PRE 14A 310617
2 GRAPHIC img265537845_0.jpg GRAPHIC 12897
3 GRAPHIC img265537845_1.jpg GRAPHIC 5049
4 GRAPHIC img265537845_2.jpg GRAPHIC 6824
5 GRAPHIC img265537845_3.jpg GRAPHIC 5183
  Complete submission text file 0000950170-23-054396.txt   353585
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39871 | Film No.: 231337427
SIC: 2836 Biological Products, (No Diagnostic Substances)